132 related articles for article (PubMed ID: 38100669)
1. Compounding and Characterization of Oral Disintegrating Films Containing Memantine Hydrochloride for Geriatrics.
Rofiq HM; Phang HC; Janakiraman AK; Chew YL; Uddin AH; Sarker ZI; Lee SK; Liew KB
Int J Pharm Compd; 2023; 27(6):512-521. PubMed ID: 38100669
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Solvent Casting and Spray Casting Method on Compounding of an Orally Disintegrating Film Containing Amlodipine Besylate.
Ruslan MFH; Janakiraman AK; Ming LC; Uddin AH; Sarker ZI; Bin LK
Int J Pharm Compd; 2022; 26(2):155-162. PubMed ID: 35413014
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the permeation and mechanical characteristics of some aqueous-based film coating systems.
Okhamafe AO; York P
J Pharm Pharmacol; 1983 Jul; 35(7):409-15. PubMed ID: 6136580
[TBL] [Abstract][Full Text] [Related]
4. Development, In Vitro and In Vivo Evaluation of Racecadotril Orodispersible Films for Pediatric Use.
Wang B; Yang L; Wang B; Luo C; Wang Y; Wang H; Chen F; Xiang X
AAPS PharmSciTech; 2021 Jan; 22(1):15. PubMed ID: 33389269
[TBL] [Abstract][Full Text] [Related]
5. Effect of polymer, plasticizer and filler on orally disintegrating film.
Liew KB; Tan YT; Peh KK
Drug Dev Ind Pharm; 2014 Jan; 40(1):110-9. PubMed ID: 23311593
[TBL] [Abstract][Full Text] [Related]
6. Hydroxypropyl Methylcellulose Orodispersible Film Containing Desloratadine for Geriatric Use: Formulation and Evaluation.
Al-Oran AYF; Yenilmez E
Antiinflamm Antiallergy Agents Med Chem; 2023; 22(2):79-91. PubMed ID: 37904551
[TBL] [Abstract][Full Text] [Related]
7. Characterization and optimization of orodispersible mosapride film formulations.
ElMeshad AN; El Hagrasy AS
AAPS PharmSciTech; 2011 Dec; 12(4):1384-92. PubMed ID: 22009305
[TBL] [Abstract][Full Text] [Related]
8. Formulation Optimization and in Vitro Characterization of Orally Disintegrating Films Using a Factorial Design and Mathematical Modeling for Drug Release.
Lee Y; Thapa P; Jeong SH; Woo MH; Choi DH
Chem Pharm Bull (Tokyo); 2017 Feb; 65(2):166-177. PubMed ID: 27904030
[TBL] [Abstract][Full Text] [Related]
9. Formulation, Characterization, and Optimization of Captopril Fast-Dissolving Oral Films.
Rezaee F; Ganji F
AAPS PharmSciTech; 2018 Jul; 19(5):2203-2212. PubMed ID: 29728997
[TBL] [Abstract][Full Text] [Related]
10. Development of a Novel Co-processed Excipitient Comprising of Xylitol, Mannitol, Microcrystalline Cellulose, and Crospovidone for the Compounding of Memantine Hydrochloride Orally Disintegrating Tablet.
Hazdi SN; Phang HC; Ng ZQ; Chew YL; Uddin AH; Sarker ZI; Lee SK; Liew KB
Int J Pharm Compd; 2023; 27(6):522-527. PubMed ID: 38100670
[TBL] [Abstract][Full Text] [Related]
11. Application of simplex lattice design and desirability function for the formulation development of mouth dissolving film of salbutamol sulphate.
Gohel MC; Parikh RK; Aghara PY; Nagori SA; Delvadia RR; Dabhi MR
Curr Drug Deliv; 2009 Oct; 6(5):486-94. PubMed ID: 19863489
[TBL] [Abstract][Full Text] [Related]
12. Gelatin/hydroxypropyl methylcellulose matrices - Polymer interactions approach for oral disintegrating films.
Tedesco MP; Monaco-Lourenço CA; Carvalho RA
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():668-74. PubMed ID: 27612760
[TBL] [Abstract][Full Text] [Related]
13. Mechanical characteristics of orally disintegrating films: Comparison of folding endurance and tensile properties.
Takeuchi Y; Ikeda N; Tahara K; Takeuchi H
Int J Pharm; 2020 Nov; 589():119876. PubMed ID: 32927004
[TBL] [Abstract][Full Text] [Related]
14. Formulation and characterization of orodispersible film containing diltiazem hydrochloride with taste masked effects.
Latif S; Kokab A; Afzal H; Shoaib QA; Hameed M; Manzoor M; Batool N; Ijaz QA
Pak J Pharm Sci; 2022 Jul; 35(4):1007-1014. PubMed ID: 36008896
[TBL] [Abstract][Full Text] [Related]
15. Formulation of Saxagliptin Oral Films: Optimization, Physicochemical Characterization, In-Vivo Assessment, and In-Vitro Real-Time Release Monitoring via a Novel Polyaniline Nanoparticles-Based Solid-Contact Screen Printed Ion-Selective Electrode.
Makram TS; Eid SM; Abu-Dahab M; AbouGhaly MHH; Elnahas OS
AAPS PharmSciTech; 2024 May; 25(5):116. PubMed ID: 38769223
[TBL] [Abstract][Full Text] [Related]
16. Development and Characterization of an Orodispersible Film for Vitamin D3 Supplementation.
Cupone IE; Dellera E; Marra F; Giori AM
Molecules; 2020 Dec; 25(24):. PubMed ID: 33322282
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of pullulan-based orally disintegrating films containing amlodipine besylate.
Pezik E; Gulsun T; Sahin S; Vural İ
Eur J Pharm Sci; 2021 Jan; 156():105597. PubMed ID: 33065224
[TBL] [Abstract][Full Text] [Related]
18. Comparative study on disintegration methods for oral film preparations.
Speer I; Steiner D; Thabet Y; Breitkreutz J; Kwade A
Eur J Pharm Biopharm; 2018 Nov; 132():50-61. PubMed ID: 30201569
[TBL] [Abstract][Full Text] [Related]
19. Formulation development and evaluation of fast dissolving film of telmisartan.
Londhe VY; Umalkar KB
Indian J Pharm Sci; 2012 Mar; 74(2):122-6. PubMed ID: 23325992
[TBL] [Abstract][Full Text] [Related]
20. Characterization of oral disintegrating film containing donepezil for Alzheimer disease.
Liew KB; Tan YT; Peh KK
AAPS PharmSciTech; 2012 Mar; 13(1):134-42. PubMed ID: 22167416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
